Urologix Targis BPH Procedure Kit Sales Growth Spurs 38% August Stock Gain
This article was originally published in The Gray Sheet
Executive Summary
Increased procedure kit sales for use with Urologix' Targis microwave catheter-based system for treatment of benign prostatic hyperplasia helped give the Minneapolis firm's stock a 38% boost in August.